The Readout Loud
Episode 32: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Is the next big idea in oncology a bust? What does "successful" mean exactly? And why does Wall Street hate biotech all of a sudden?